
Dr. Gelareh Zadeh - Editor-in-Chief of the Neuro-Oncology Advances Journal https://xitter.cf/t.co/DIZeqLXgdx @gelarehzadeh
Joined February 2022
- Tweets840
- Following366
- Followers1.7K
- Likes3.2K
We welcome working with you on manuscripts in any area of #braintumor #CancerResearch #cancercare #spinetumors #metastases #pediatricbraintumor #molecularpathology #Neurosurgery #neuroscience of #braincancer & more
[email protected]
academic.oup.com/noa
Editor - Neuro-Oncology Advances retweeted
Deeply honored and grateful 🙏 to be selected as SNO Executive Editor for NeuroOncology Advances @EditorNeuro @NeuroOnc
Looking forward to working with EiC @wick_wolfgang, fellow dedicated editors, thoughtful authors and broad neuroonc community to amplify #impactful #research.
As my term as #EIC has come to an end, I want to thank everyone who has made #NOA a successful internationally reocgnized journal.
Thank you to our readers, authors, reviewers, editors, @OUPAcademic, @NeuroOnc & @EANOassociation for helping further advances in #NeuroOncology
I am delighted to welcome @wick_wolfgang as the new Editor-in-Chief of #NeuroOncologyAdvances. As I pass the torch, I do so with pride in what we have built together and look forward to seeing the journal grow under his leadership.
The achievements of NOA have always been the result of teamwork. Thank you to the exceptional group of executive and associate #editors I’ve had the privilege to work with over the past seven years whose dedication, insight, and commitment to quality shaped the journal.
A letter from @gelarehzadeh on her term as Editor-in-Chief of #NeuroOncologyAdvances coming to a close.
Our new supplement on #SingleCell Technologies is now available!
Click here for open access articles: bit.ly/3NqbDCb
Read the systematic literature review around disease burden and unmet needs in adults with #neurofibromatosis type 1 and #PlexiformNeurofibromas in our latest issue:
bit.ly/3Nf9JnQ
Unlike cancers with successful fusion-targeted treatments, the incidence and therapeutic potential of #GeneFusions in #glioblastoma remain unclear. This article analyzes a large genomic database to define fusion frequency and molecular associations.
bit.ly/4c4der6
Read our new review examining the interplay between key immune system components and the #microbiota in #glioblastoma development and how this understanding could facilitate the development of novel therapeutic interventions:
bit.ly/4rher2k
Our new article on the #glioblastoma #GBMdrug1000 dataset resource providing directions for future small molecule drug discovery is now available.
Read here: academic.oup.com/noa/article…
This study evaluates diagnostic timelines and their influencing factors, treatment patterns, and their impact on survival in patients with Primary central nervous system lymphoma (#PCNSL).
Read the full article here: bit.ly/3PaHC9M
We’re pleased to offer #LaySummaries for many of our recent articles. You can read them by navigating to our latest issue and clicking the ‘Lay Summary’ drop down below the title.
academic.oup.com/noa/issue/8…
The molecular tumor board case report “A case of #radiation treatment effect mimicking viable, recurrent #meningioma on #DOTATATE PET imaging” is now available in our latest issue:
bit.ly/4c4lsQ2
This recent investigation analyzed a large #genomic database to define fusion frequency and molecular associations.
Read the #LaySummary or full article here: academic.oup.com/noa/article…
“Improved target volume delineation for #StereotacticRadiosurgery in #BrainMetastases using post-contrast 3D T1 TSE black-blood #MRI” is now available in our latest issue:
bit.ly/4qcHRy3
What are the clinical, morphological and molecular features of desmoplastic infantile #ganglioglioma/#astrocytoma?
Read the recent #ClinicalInvestigation:
bit.ly/3MiNkW8
Read the study evaluating how #MolecularPathology and clinical features influence surgical outcomes in patients with WHO grade 4 #gliomas, including isocitrate dehydrogenase (#IDH)-mutant astrocytomas and IDH wild-type #glioblastomas.
bit.ly/4aqG7MX
Read the article on “Age-dependent #glioma #progression and functional decline in a syngeneic #murine model: Host vulnerabilities and opportunities for targeted intervention” in our new issue:
bit.ly/4kb9S7V
Editor - Neuro-Oncology Advances retweeted
Thank you to the organizers of our upcoming NASBS/ICOM #Meningioma Education Day, @gelarehzadeh @FarshadNassiri @ap_landry @michaelivanmd and Paul Gardner.
You can learn more about the agenda or register as part of the @NASBSorg 2026 Meeting here: nasbs.org/icom-meningioma-da…
































